Cargando…
New-onset IgA nephropathy following COVID-19 vaccination
Coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused significant economic and health damage worldwide. Rapid vaccination is one of the key strategies to curb severe illness and death due to SARS-CoV-2 infection. Hundreds...
Autores principales: | Ma, Yaohui, Xu, Gaosi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450102/ https://www.ncbi.nlm.nih.gov/pubmed/35920797 http://dx.doi.org/10.1093/qjmed/hcac185 |
Ejemplares similares
-
Correction to: New-onset IgA nephropathy following COVID-19 vaccination
Publicado: (2022) -
An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective
por: Huang, Xin, et al.
Publicado: (2021) -
New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 Vaccination
por: Ma, Qiqi, et al.
Publicado: (2022) -
The role of mononuclear phagocyte system in IgA nephropathy: pathogenesis and prognosis
por: Liu, Yiwen, et al.
Publicado: (2023) -
IgA nephropathy following COVID-19 vaccination: challenges and perspectives
por: Niel, Olivier, et al.
Publicado: (2022)